MedPath

贵州拜特制药有限公司

Ownership
-
Established
1994-07-16
Employees
-
Market Cap
-
Website
http://www.tjtzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

苑叶止咳糖浆

Approval Number
国药准字Z20027665
Approval Date
Dec 6, 2019
NMPA

痔疾栓

Approval Number
国药准字Z20064194
Approval Date
Jul 3, 2018
NMPA

麝香舒活搽剂

Approval Number
国药准字Z20073220
Approval Date
Jan 22, 2017
NMPA

Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection

Product Name
丹参川芎嗪注射液
Approval Number
国药准字H52020959
Approval Date
Sep 21, 2015
NMPA

Ampicillin Capsules

Product Name
氨苄西林胶囊
Approval Number
国药准字H52020542
Approval Date
Jun 29, 2015
NMPA

健儿消食口服液

Approval Number
国药准字Z20054543
Approval Date
Jun 11, 2015
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.